Mo Hong

750 total citations
34 papers, 653 citations indexed

About

Mo Hong is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Mo Hong has authored 34 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Mo Hong's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacological Effects of Natural Compounds (5 papers). Mo Hong is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacological Effects of Natural Compounds (5 papers). Mo Hong collaborates with scholars based in China, United States and Japan. Mo Hong's co-authors include Yun‐Feng Cao, Zhong‐Ze Fang, Xiaoyu Sun, Cuimin Hu, R. J. Highet, J. A. Hinson, L R Pohl, T J Monks, Yanyan Zhang and Xiaoyu Sun and has published in prestigious journals such as Journal of Geophysical Research Atmospheres, Geophysical Research Letters and Chemosphere.

In The Last Decade

Mo Hong

34 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mo Hong China	16	304	266	101	92	77	34	653
Weijing Qu China	18	620 2.0×	71 0.3×	79 0.8×	68 0.7×	148 1.9×	49	1.3k
Dayong Si China	12	176 0.6×	310 1.2×	155 1.5×	9 0.1×	147 1.9×	22	571
Richard R. Erickson United States	14	212 0.7×	206 0.8×	88 0.9×	9 0.1×	39 0.5×	29	630
William H. Schaefer United States	16	415 1.4×	129 0.5×	72 0.7×	4 0.0×	60 0.8×	21	822
E. Moro Italy	15	126 0.4×	91 0.3×	86 0.9×	2 0.0×	143 1.9×	33	549
Ding Xiao-ping China	15	211 0.7×	85 0.3×	18 0.2×		60 0.8×	47	655
Gwendolyn E. Kuehl United States	7	139 0.5×	158 0.6×	72 0.7×	2 0.0×	85 1.1×	8	372
Aleksanteri Petsalo Finland	17	299 1.0×	262 1.0×	164 1.6×		58 0.8×	24	682

Countries citing papers authored by Mo Hong

Since Specialization

Citations

This map shows the geographic impact of Mo Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Hong more than expected).

Fields of papers citing papers by Mo Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Hong. The network helps show where Mo Hong may publish in the future.

Co-authorship network of co-authors of Mo Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Hong. A scholar is included among the top collaborators of Mo Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Hong. Mo Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hong, Mo, et al.. (2022). Association of amino acids related to urea cycle with risk of diabetic nephropathy in two independent cross-sectional studies of Chinese adults. Frontiers in Endocrinology. 13. 983747–983747. 4 indexed citations

Wang, Shuang, Yun‐Feng Cao, Xiaoyu Sun, et al.. (2021). Plasma Amino Acids and Residual Hypertriglyceridemia in Diabetic Patients Under Statins: Two Independent Cross-Sectional Hospital-Based Cohorts. Frontiers in Cardiovascular Medicine. 8. 605716–605716. 2 indexed citations

Wang, Guo-En, Yi-Fang Li, Yujia Zhai, et al.. (2018). Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism. Metabolism. 85. 227–239. 39 indexed citations

Zhang, Xuxin, Yanzhao Li, Yan Liang, et al.. (2017). Distinguishing Intracerebral Hemorrhage from Acute Cerebral Infarction through Metabolomics. Revista de investigaci�n Cl�nica. 69(6). 319–328. 27 indexed citations

Wang, Xinxin, et al.. (2016). [Inhibition of sciadopitysin against UDP-glucuronosyltransferases].. PubMed. 51(5). 749–55. 5 indexed citations

Ma, Haiying, Dongxue Sun, Yun‐Feng Cao, et al.. (2014). Herb–drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7. Toxicology and Applied Pharmacology. 277(1). 86–94. 28 indexed citations

Cao, Yun‐Feng, Mo Hong, Dongxue Sun, et al.. (2014). The Inhibition of the Components from Shengmai Injection towards UDP‐Glucuronosyltransferase. Evidence-based Complementary and Alternative Medicine. 2014(1). 594354–594354. 8 indexed citations

Fang, Zhong‐Ze, Haina Wang, Yun‐Feng Cao, et al.. (2014). Enantioselective Inhibition of Carprofen Towards UDP‐glucuronosyltransferase (UGT) 2B7. Chirality. 27(3). 189–193. 10 indexed citations

Gao, Xin, Chun‐Zhi Ai, Yun‐Feng Cao, et al.. (2014). Regulation profile of phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) components towards UDP-glucuronosyltransferases (UGTs) isoforms. Xenobiotica. 45(3). 197–206. 14 indexed citations

10.

Liu, Xin, Ting Huang, Jianxing Chen, et al.. (2013). Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.. PubMed. 68(12). 945–50. 8 indexed citations

11.

Cao, Yun‐Feng, Cuimin Hu, Zhong‐Ze Fang, et al.. (2013). Comparison of Inhibition Capability of Scutellarein and Scutellarin Towards Important Liver UDP‐Glucuronosyltransferase (UGT) Isoforms. Phytotherapy Research. 28(3). 382–386. 20 indexed citations

12.

Fang, Zhong‐Ze, Yun‐Feng Cao, Cuimin Hu, et al.. (2013). Structure–inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs). Toxicology and Applied Pharmacology. 267(2). 149–154. 51 indexed citations

13.

Fang, Zhong‐Ze, Rong‐Rong He, Yun‐Feng Cao, et al.. (2013). A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders. Journal of Lipid Research. 54(12). 3334–3344. 31 indexed citations

14.

He, Haibing, et al.. (2012). Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability. Drug Development and Industrial Pharmacy. 38(10). 1221–1229. 13 indexed citations

15.

Liu, Cong, Yun‐Feng Cao, Zhong‐Ze Fang, et al.. (2012). Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction. Fitoterapia. 83(8). 1415–1419. 32 indexed citations

16.

Fang, Zhong‐Ze, Yun‐Feng Cao, Cuimin Hu, et al.. (2012). Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation. Fitoterapia. 84. 208–212. 17 indexed citations

17.

Guo, Bin, Zhong‐Ze Fang, Yun‐Feng Cao, et al.. (2012). Deglycosylation of Liquiritin Strongly Enhances its Inhibitory Potential Towards UDP‐Glucuronosyltransferase (UGT) Isoforms. Phytotherapy Research. 27(8). 1232–1236. 19 indexed citations

18.

Li, Guofei, Lili Zhang, Xiaoguang Tao, et al.. (2010). Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin. International Journal of Pharmaceutics. 400(1-2). 42–48. 13 indexed citations

19.

Hong, Mo. (2005). Ant-RSV effects of Shuanghuanglian and Its disassembled prescriptions. 1 indexed citations

20.

Hinson, J. A., T J Monks, Mo Hong, R. J. Highet, & L R Pohl. (1982). 3-(glutathion-S-yl)acetaminophen: a biliary metabolite of acetaminophen.. Drug Metabolism and Disposition. 10(1). 47–50. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact